Literature DB >> 30337087

[Benzodiazepines, cognitive decline and dementia: A review of causality criteria from published observational studies].

Maryse Lapeyre-Mestre1.   

Abstract

OBJECTIVE: Benzodiazepines are a source of well-known adverse reactions related to their pharmacological properties: memory disorders, falls in the elderly, confusion and sedation, drug addiction. The impact of their chronic use on cognitive decline and dementia has been the subject of many studies for two decades.
METHODS: From 25 studies identified in the international literature from 1997 to 2017, the Bradford-Hill causality criteria were systematically applied.
RESULTS: Fifteen studies found a statistically significant association with a deleterious effect, two a protective effect and eight did not find any association. The most recent studies using a longer delay to take into account a protopathic bias did not find any association or any dose-effect relationship. The majority of studies suggest impaired cognitive functions for contemporary consumption or those closest to the event being studied. Finally, the biological plausibility remains discussed.
CONCLUSION: The question of the role of benzodiazepines in the onset of dementia remains open, and other studies attempting to limit previous methodological drawbacks should be carried out.
Copyright © 2018 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Benzodiazepines; Benzodiazépines; Cognitive decline; Composés Z; Dementia; Déclin cognitif; Démence; Z-compounds

Mesh:

Substances:

Year:  2018        PMID: 30337087     DOI: 10.1016/j.therap.2018.09.071

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  5 in total

1.  Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews.

Authors:  Patrícia Ferreira; Ana Rita Ferreira; Beatriz Barreto; Lia Fernandes
Journal:  Eur Geriatr Med       Date:  2021-08-17       Impact factor: 1.710

2.  Assess of Combinations of Non-Pharmacological Interventions for the Reduction of Irritability in Patients with Dementia and their Caregivers: A Cross-Over RCT.

Authors:  Tatiana Dimitriou; John Papatriantafyllou; Anastasia Konsta; Dimitrios Kazis; Loukas Athanasiadis; Panagiotis Ioannidis; Efrosini Koutsouraki; Thomas Tegos; Magda Tsolaki
Journal:  Brain Sci       Date:  2022-05-26

3.  The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies.

Authors:  Linzi Liu; Linna Jia; Peiying Jian; Yifang Zhou; Jian Zhou; Feng Wu; Yanqing Tang
Journal:  Front Psychiatry       Date:  2020-09-17       Impact factor: 4.157

4.  Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review.

Authors:  Gaetan Gentile; Maryse Lapeyre-Mestre; Joelle Micallef
Journal:  BJGP Open       Date:  2020-05-01

5.  Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study.

Authors:  Kristien Coteur; Pavlos Mamouris; Bert Vaes; Marc Van Nuland; Catharina Matheï; Birgitte Schoenmakers
Journal:  Front Public Health       Date:  2022-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.